{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T15:38:34Z","timestamp":1786981114120,"version":"build-2736575974"},"reference-count":87,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2023,1,30]],"date-time":"2023-01-30T00:00:00Z","timestamp":1675036800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,1,30]],"date-time":"2023-01-30T00:00:00Z","timestamp":1675036800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"the National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82171053"],"award-info":[{"award-number":["82171053"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"the National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82171053"],"award-info":[{"award-number":["82171053"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"the National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82171053"],"award-info":[{"award-number":["82171053"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"the National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82171053"],"award-info":[{"award-number":["82171053"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"he Natural Science Foundation of Jilin Province","award":["20200801043GH"],"award-info":[{"award-number":["20200801043GH"]}]},{"name":"he Natural Science Foundation of Jilin Province","award":["20200801043GH"],"award-info":[{"award-number":["20200801043GH"]}]},{"name":"he Natural Science Foundation of Jilin Province","award":["20200801043GH"],"award-info":[{"award-number":["20200801043GH"]}]},{"name":"he Natural Science Foundation of Jilin Province","award":["20200801043GH"],"award-info":[{"award-number":["20200801043GH"]}]},{"name":"the Natural Science Foundation of Jilin Province","award":["20190201083JC"],"award-info":[{"award-number":["20190201083JC"]}]},{"name":"the Natural Science Foundation of Jilin Province","award":["20190201083JC"],"award-info":[{"award-number":["20190201083JC"]}]},{"name":"the Natural Science Foundation of Jilin Province","award":["20190201083JC"],"award-info":[{"award-number":["20190201083JC"]}]},{"name":"the Natural Science Foundation of Jilin Province","award":["20190201083JC"],"award-info":[{"award-number":["20190201083JC"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int Ophthalmol"],"DOI":"10.1007\/s10792-023-02637-x","type":"journal-article","created":{"date-parts":[[2023,1,30]],"date-time":"2023-01-30T03:03:29Z","timestamp":1675047809000},"page":"2575-2588","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":27,"title":["Implantable sustained-release drug delivery systems: a revolution for ocular therapeutics"],"prefix":"10.1007","volume":"43","author":[{"given":"Yun-Yi","family":"Cong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zi-Yuan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guang-Yu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,1,30]]},"reference":[{"key":"2637_CR1","doi-asserted-by":"publisher","first-page":"1564","DOI":"10.1016\/j.biopha.2018.08.138","volume":"107","author":"K Nayak","year":"2018","unstructured":"Nayak K, Misra M (2018) A review on recent drug delivery systems for posterior segment of eye. Biomed Pharmacother 107:1564\u20131582. https:\/\/doi.org\/10.1016\/j.biopha.2018.08.138","journal-title":"Biomed Pharmacother"},{"issue":"9","key":"2637_CR2","doi-asserted-by":"publisher","first-page":"2385","DOI":"10.1007\/s10792-020-01391-8","volume":"40","author":"F Rafiei","year":"2020","unstructured":"Rafiei F, Tabesh H, Farzad F (2020) Sustained subconjunctival drug delivery systems: current trends and future perspectives. Int Ophthalmol 40(9):2385\u20132401. https:\/\/doi.org\/10.1007\/s10792-020-01391-8","journal-title":"Int Ophthalmol"},{"issue":"6","key":"2637_CR3","doi-asserted-by":"publisher","first-page":"683","DOI":"10.2217\/nnm-2016-0379","volume":"12","author":"RR Joseph","year":"2017","unstructured":"Joseph RR, Venkatraman SS (2017) Drug delivery to the eye: what benefits do nanocarriers offer? Nanomedicine Lond 12(6):683\u2013702. https:\/\/doi.org\/10.2217\/nnm-2016-0379","journal-title":"Nanomedicine Lond"},{"issue":"12","key":"2637_CR4","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1007\/s11095-018-2519-x","volume":"35","author":"GA Rodrigues","year":"2018","unstructured":"Rodrigues GA, Lutz D, Shen J, Yuan X, Shen H, Cunningham J, Rivers HM (2018) Topical drug delivery to the posterior segment of the eye: addressing the challenge of preclinical to clinical translation. Pharm Res 35(12):245. https:\/\/doi.org\/10.1007\/s11095-018-2519-x","journal-title":"Pharm Res"},{"issue":"10","key":"2637_CR5","doi-asserted-by":"publisher","first-page":"1685","DOI":"10.3390\/pharmaceutics13101685","volume":"13","author":"AM Burhan","year":"2021","unstructured":"Burhan AM, Klahan B, Cummins W, Andr\u00e9s-Guerrero V, Byrne ME, O\u2019Reilly NJ, Chauhan A, Fitzhenry L, Hughes H (2021) Posterior Segment ophthalmic drug delivery: role of Muco-adhesion with a special focus on chitosan. Pharmaceutics 13(10):1685. https:\/\/doi.org\/10.3390\/pharmaceutics13101685","journal-title":"Pharmaceutics"},{"issue":"23","key":"2637_CR6","doi-asserted-by":"publisher","first-page":"4205","DOI":"10.1111\/bph.14024","volume":"174","author":"S Awwad","year":"2017","unstructured":"Awwad S, Mohamed Ahmed AHA, Sharma G, Heng JS, Khaw PT, Brocchini S, Lockwood A (2017) Principles of pharmacology in the eye. Br J Pharmacol 174(23):4205\u20134223. https:\/\/doi.org\/10.1111\/bph.14024","journal-title":"Br J Pharmacol"},{"issue":"1","key":"2637_CR7","doi-asserted-by":"publisher","first-page":"108","DOI":"10.3390\/pharmaceutics13010108","volume":"13","author":"HM Kim","year":"2021","unstructured":"Kim HM, Woo SJ (2021) Ocular drug delivery to the retina: current innovations and future perspectives. Pharmaceutics 13(1):108. https:\/\/doi.org\/10.3390\/pharmaceutics13010108","journal-title":"Pharmaceutics"},{"issue":"3","key":"2637_CR8","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1124\/jpet.119.256933","volume":"370","author":"V Gote","year":"2019","unstructured":"Gote V, Sikder S, Sicotte J, Pal D (2019) Ocular drug delivery: present innovations and future challenges. J Pharmacol Exp Ther 370(3):602\u2013624. https:\/\/doi.org\/10.1124\/jpet.119.256933","journal-title":"J Pharmacol Exp Ther"},{"issue":"1","key":"2637_CR9","doi-asserted-by":"publisher","first-page":"134","DOI":"10.3390\/pharmaceutics14010134","volume":"14","author":"M L\u00f6scher","year":"2022","unstructured":"L\u00f6scher M, Seiz C, Hurst J, Schnichels S (2022) Topical drug delivery to the posterior segment of the eye. Pharmaceutics 14(1):134. https:\/\/doi.org\/10.3390\/pharmaceutics14010134","journal-title":"Pharmaceutics"},{"issue":"2","key":"2637_CR10","doi-asserted-by":"publisher","first-page":"144","DOI":"10.2174\/1567201814666170508104254","volume":"15","author":"S Mittal","year":"2018","unstructured":"Mittal S, Miranda O (2018) Recent advancemnts in biodegradable ocular implants. Curr Drug Deliv 15(2):144\u2013154. https:\/\/doi.org\/10.2174\/1567201814666170508104254","journal-title":"Curr Drug Deliv"},{"key":"2637_CR11","doi-asserted-by":"publisher","first-page":"120924","DOI":"10.1016\/j.ijpharm.2021.120924","volume":"607","author":"M Mofidfar","year":"2021","unstructured":"Mofidfar M, Abdi B, Ahadian S, Mostafavi E, Desai TA, Abbasi F, Sun Y, Manche EE, Ta CN, Flowers CW (2021) Drug delivery to the anterior segment of the eye: a review of current and future treatment strategies. Int J Pharm 607:120924. https:\/\/doi.org\/10.1016\/j.ijpharm.2021.120924","journal-title":"Int J Pharm"},{"issue":"10","key":"2637_CR12","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1080\/17425255.2020.1803278","volume":"16","author":"V Gote","year":"2020","unstructured":"Gote V, Ansong M, Pal D (2020) Prodrugs and nanomicelles to overcome ocular barriers for drug penetration. Expert Opin Drug Metab Toxicol 16(10):885\u2013906. https:\/\/doi.org\/10.1080\/17425255.2020.1803278","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"2637_CR13","doi-asserted-by":"publisher","first-page":"120332","DOI":"10.1016\/j.ijpharm.2021.120332","volume":"597","author":"S Sripetch","year":"2021","unstructured":"Sripetch S, Loftsson T (2021) Topical drug delivery to the posterior segment of the eye: thermodynamic considerations. Int J Pharm 597:120332. https:\/\/doi.org\/10.1016\/j.ijpharm.2021.120332","journal-title":"Int J Pharm"},{"key":"2637_CR14","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.addr.2017.09.008","volume":"126","author":"D Huang","year":"2018","unstructured":"Huang D, Chen YS, Rupenthal ID (2018) Overcoming ocular drug delivery barriers through the use of physical forces. Adv Drug Deliv Rev 126:96\u2013112. https:\/\/doi.org\/10.1016\/j.addr.2017.09.008","journal-title":"Adv Drug Deliv Rev"},{"issue":"3","key":"2637_CR15","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1080\/17425247.2018.1406918","volume":"15","author":"SK Li","year":"2018","unstructured":"Li SK, Hao J (2018) Transscleral passive and iontophoretic transport: theory and analysis. Expert Opin Drug Deliv 15(3):283\u2013299. https:\/\/doi.org\/10.1080\/17425247.2018.1406918","journal-title":"Expert Opin Drug Deliv"},{"key":"2637_CR16","doi-asserted-by":"publisher","first-page":"797428","DOI":"10.3389\/fmed.2021.797428","volume":"8","author":"YH Kim","year":"2021","unstructured":"Kim YH, Oh J (2021) Choroidal thickness profile in chorioretinal diseases: beyond the macula. Front Med Lausanne 8:797428. https:\/\/doi.org\/10.3389\/fmed.2021.797428","journal-title":"Front Med Lausanne"},{"key":"2637_CR17","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.addr.2017.09.007","volume":"126","author":"K Peynshaert","year":"2018","unstructured":"Peynshaert K, Devoldere J, De Smedt SC, Remaut K (2018) In vitro and ex vivo models to study drug delivery barriers in the posterior segment of the eye. Adv Drug Deliv Rev 126:44\u201357. https:\/\/doi.org\/10.1016\/j.addr.2017.09.007","journal-title":"Adv Drug Deliv Rev"},{"key":"2637_CR18","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.preteyeres.2016.12.001","volume":"57","author":"EM Del Amo","year":"2017","unstructured":"Del Amo EM, Rimpel\u00e4 AK, Heikkinen E, Kari OK, Ramsay E, Lajunen T, Schmitt M, Pelkonen L, Bhattacharya M, Richardson D, Subrizi A, Turunen T, Reinisalo M, Itkonen J, Toropainen E, Casteleijn M, Kidron H, Antopolsky M, Vellonen KS, Ruponen M, Urtti A (2017) Pharmacokinetic aspects of retinal drug delivery. Prog Retin Eye Res 57:134\u2013185. https:\/\/doi.org\/10.1016\/j.preteyeres.2016.12.001","journal-title":"Prog Retin Eye Res"},{"issue":"1","key":"2637_CR19","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1080\/17425247.2022.2017878","volume":"19","author":"T Loftsson","year":"2022","unstructured":"Loftsson T (2022) Topical drug delivery to the retina: obstacles and routes to success. Expert Opin Drug Deliv 19(1):9\u201321. https:\/\/doi.org\/10.1080\/17425247.2022.2017878","journal-title":"Expert Opin Drug Deliv"},{"issue":"3","key":"2637_CR20","doi-asserted-by":"publisher","first-page":"269","DOI":"10.3390\/pharmaceutics12030269","volume":"12","author":"R Varela-Fern\u00e1ndez","year":"2020","unstructured":"Varela-Fern\u00e1ndez R, D\u00edaz-Tom\u00e9 V, Luaces-Rodr\u00edguez A, Conde-Penedo A, Garc\u00eda-Otero X, Luzardo-\u00c1lvarez A, Fern\u00e1ndez-Ferreiro A, Otero-Espinar FJ (2020) Drug delivery to the posterior segment of the eye: biopharmaceutic and pharmacokinetic considerations. Pharmaceutics 12(3):269. https:\/\/doi.org\/10.3390\/pharmaceutics12030269","journal-title":"Pharmaceutics"},{"issue":"9","key":"2637_CR21","doi-asserted-by":"publisher","first-page":"1672","DOI":"10.1016\/j.drudis.2018.06.009","volume":"23","author":"B Pavan","year":"2018","unstructured":"Pavan B, Dalpiaz A (2018) Retinal pigment epithelial cells as a therapeutic tool and target against retinopathies. Drug Discov Today 23(9):1672\u20131679. https:\/\/doi.org\/10.1016\/j.drudis.2018.06.009","journal-title":"Drug Discov Today"},{"issue":"1\u20132","key":"2637_CR22","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1016\/j.ijpharm.2017.07.065","volume":"530","author":"A Madni","year":"2017","unstructured":"Madni A, Rahem MA, Tahir N, Sarfraz M, Jabar A, Rehman M, Kashif PM, Badshah SF, Khan KU, Santos HA (2017) Non-invasive strategies for targeting the posterior segment of eye. Int J Pharm 530(1\u20132):326\u2013345. https:\/\/doi.org\/10.1016\/j.ijpharm.2017.07.065","journal-title":"Int J Pharm"},{"issue":"2","key":"2637_CR23","doi-asserted-by":"publisher","first-page":"82","DOI":"10.3390\/gels8020082","volume":"8","author":"MH Akhter","year":"2022","unstructured":"Akhter MH, Ahmad I, Alshahrani MY, Al-Harbi AI, Khalilullah H, Afzal O, Altamimi ASA, Najib Ullah SNM, Ojha A, Karim S (2022) Drug delivery challenges and current progress in nanocarrier-based ocular therapeutic system. Gels 8(2):82. https:\/\/doi.org\/10.3390\/gels8020082","journal-title":"Gels"},{"issue":"2","key":"2637_CR24","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1089\/jop.2015.0047","volume":"32","author":"VK Yellepeddi","year":"2016","unstructured":"Yellepeddi VK, Palakurthi S (2016) Recent advances in topical ocular drug delivery. J Ocul Pharmacol Ther 32(2):67\u201382. https:\/\/doi.org\/10.1089\/jop.2015.0047","journal-title":"J Ocul Pharmacol Ther"},{"key":"2637_CR25","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.addr.2017.12.009","volume":"126","author":"KS Vellonen","year":"2018","unstructured":"Vellonen KS, Hellinen L, Mannermaa E, Ruponen M, Urtti A, Kidron H (2018) Expression, activity and pharmacokinetic impact of ocular transporters. Adv Drug Deliv Rev 126:3\u201322. https:\/\/doi.org\/10.1016\/j.addr.2017.12.009","journal-title":"Adv Drug Deliv Rev"},{"issue":"8","key":"2637_CR26","doi-asserted-by":"publisher","first-page":"1458","DOI":"10.1016\/j.drudis.2019.03.023","volume":"24","author":"Y Agban","year":"2019","unstructured":"Agban Y, Thakur SS, Mugisho OO, Rupenthal ID (2019) Depot formulations to sustain periocular drug delivery to the posterior eye segment. Drug Discov Today 24(8):1458\u20131469. https:\/\/doi.org\/10.1016\/j.drudis.2019.03.023","journal-title":"Drug Discov Today"},{"key":"2637_CR27","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.addr.2017.12.008","volume":"126","author":"AK Rimpel\u00e4","year":"2018","unstructured":"Rimpel\u00e4 AK, Reinisalo M, Hellinen L, Grazhdankin E, Kidron H, Urtti A, Del Amo EM (2018) Implications of melanin binding in ocular drug delivery. Adv Drug Deliv Rev 126:23\u201343. https:\/\/doi.org\/10.1016\/j.addr.2017.12.008","journal-title":"Adv Drug Deliv Rev"},{"key":"2637_CR28","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.ejpb.2021.12.002","volume":"170","author":"YN Teng","year":"2022","unstructured":"Teng YN, Chen LH, Chen Kui Vavulengan YH (2022) Repositioning application of polyoxyethylene (20) sorbitan monooleate on ocular drug resistance and cancer multi-drug resistance by inhibiting the ATPase activity of human multidrug resistance protein 1 and P-glycoprotein. Eur J Pharm Biopharm 170:77\u201390. https:\/\/doi.org\/10.1016\/j.ejpb.2021.12.002","journal-title":"Eur J Pharm Biopharm"},{"issue":"8","key":"2637_CR29","doi-asserted-by":"publisher","first-page":"2128","DOI":"10.1177\/1747493018778713","volume":"107","author":"KY Janga","year":"2018","unstructured":"Janga KY, Tatke A, Shukla S, Lamichhane SP, Avula B, Wang X, Jablonski MM, Khan IA, Majumdar S (2018) Retina compatible interactions and effective modulation of blood ocular barrier P-gp activity by third-generation inhibitors improve the ocular penetration of loperamide. J Pharm Sci 107(8):2128\u20132135. https:\/\/doi.org\/10.1177\/1747493018778713","journal-title":"J Pharm Sci"},{"issue":"1","key":"2637_CR30","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1007\/s13318-016-0319-4","volume":"42","author":"N Djebli","year":"2017","unstructured":"Djebli N, Khier S, Griguer F, Coutant AL, Tavernier A, Fabre G, Leriche C, Fabre D (2017) Ocular drug distribution after topical administration: population pharmacokinetic model in rabbits. Eur J Drug Metab Pharmacokinet 42(1):59\u201368. https:\/\/doi.org\/10.1007\/s13318-016-0319-4","journal-title":"Eur J Drug Metab Pharmacokinet"},{"issue":"1","key":"2637_CR31","doi-asserted-by":"publisher","first-page":"28","DOI":"10.3390\/pharmaceutics10010028","volume":"10","author":"RD Bachu","year":"2018","unstructured":"Bachu RD, Chowdhury P, Al-Saedi ZHF, Karla PK, Boddu SHS (2018) Ocular drug delivery barriers-role of nanocarriers in the treatment of anterior segment ocular diseases. Pharmaceutics 10(1):28. https:\/\/doi.org\/10.3390\/pharmaceutics10010028","journal-title":"Pharmaceutics"},{"issue":"6","key":"2637_CR32","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1089\/jop.2019.0109","volume":"36","author":"ME Durgun","year":"2020","unstructured":"Durgun ME, G\u00fcng\u00f6r S, \u00d6zsoy Y (2020) Micelles: promising ocular drug carriers for anterior and posterior segment diseases. J Ocul Pharmacol Ther 36(6):323\u2013341. https:\/\/doi.org\/10.1089\/jop.2019.0109","journal-title":"J Ocul Pharmacol Ther"},{"issue":"6","key":"2637_CR33","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1080\/10837450.2020.1733606","volume":"25","author":"M Alami-Milani","year":"2020","unstructured":"Alami-Milani M, Zakeri-Milani P, Valizadeh H, Fathi M, Salatin S, Salehi R, Jelvehgari M (2020) PLA-PCL-PEG-PCL-PLA based micelles for improving the ocular permeability of dexamethasone: development, characterization, and in vitro evaluation. Pharm Dev Technol 25(6):704\u2013719. https:\/\/doi.org\/10.1080\/10837450.2020.1733606","journal-title":"Pharm Dev Technol"},{"issue":"2","key":"2637_CR34","doi-asserted-by":"publisher","first-page":"153","DOI":"10.22038\/IJBMS.2017.26590.6513","volume":"21","author":"M Alami-Milani","year":"2018","unstructured":"Alami-Milani M, Zakeri-Milani P, Valizadeh H, Salehi R, Jelvehgari M (2018) Preparation and evaluation of PCL-PEG-PCL micelles as potential nanocarriers for ocular delivery of dexamethasone. Iran J Basic Med Sci 21(2):153\u2013164. https:\/\/doi.org\/10.22038\/IJBMS.2017.26590.6513","journal-title":"Iran J Basic Med Sci"},{"issue":"2","key":"2637_CR35","doi-asserted-by":"publisher","first-page":"228","DOI":"10.3390\/pharmaceutics13020228","volume":"13","author":"D Barbosa-Alfaro","year":"2021","unstructured":"Barbosa-Alfaro D, Andr\u00e9s-Guerrero V, Fernandez-Bueno I, Garc\u00eda-Guti\u00e9rrez MT, Gil-Alegre E, Molina-Mart\u00ednez IT, Pastor-Jimeno JC, Herrero-Vanrell R, Bravo-Osuna I (2021) Dexamethasone PLGA microspheres for sub-tenon administration: influence of sterilization and tolerance studies. Pharmaceutics 13(2):228. https:\/\/doi.org\/10.3390\/pharmaceutics13020228","journal-title":"Pharmaceutics"},{"issue":"1","key":"2637_CR36","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1111\/aos.14175","volume":"98","author":"JM Lindholm","year":"2020","unstructured":"Lindholm JM, Taipale C, Ylinen P, Tuuminen R (2020) Perioperative subconjunctival triamcinolone acetonide injection for prevention of inflammation and macular oedema after cataract surgery. ACTA Ophthalmol 98(1):36\u201342. https:\/\/doi.org\/10.1111\/aos.14175","journal-title":"ACTA Ophthalmol"},{"issue":"9","key":"2637_CR37","doi-asserted-by":"publisher","first-page":"3279","DOI":"10.3109\/10717544.2016.1172368","volume":"23","author":"B Yavuz","year":"2016","unstructured":"Yavuz B, Bozda\u011f Pehlivan S, Kaffashi A, \u00c7alamak S, Ulubayram K, Palaska E, \u00c7akmak HB, \u00dcnl\u00fc N (2016) In vivo tissue distribution and efficacy studies for cyclosporin a loaded nano-decorated subconjunctival implants. Drug Deliv 23(9):3279\u20133284. https:\/\/doi.org\/10.3109\/10717544.2016.1172368","journal-title":"Drug Deliv"},{"issue":"7","key":"2637_CR38","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1080\/1061186X.2021.1878366","volume":"29","author":"R Wang","year":"2021","unstructured":"Wang R, Gao Y, Liu A, Zhai G (2021) A review of nanocarrier-mediated drug delivery systems for posterior segment eye disease: challenges analysis and recent advances. J Drug Target 29(7):687\u2013702. https:\/\/doi.org\/10.1080\/1061186X.2021.1878366","journal-title":"J Drug Target"},{"issue":"3","key":"2637_CR39","doi-asserted-by":"publisher","first-page":"849","DOI":"10.3109\/10717544.2014.919543","volume":"23","author":"Z Huang","year":"2016","unstructured":"Huang Z, Yang W, Zong Y, Qiu S, Chen X, Sun X, Zhou Y, Xie Z, Gao Q (2016) A study of the dexamethasone sodium phosphate release properties from a periocular capsular drug delivery system. Drug Deliv 23(3):849\u2013857. https:\/\/doi.org\/10.3109\/10717544.2014.919543","journal-title":"Drug Deliv"},{"issue":"1","key":"2637_CR40","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1080\/10717544.2017.1324531","volume":"24","author":"X Huang","year":"2017","unstructured":"Huang X, Peng M, Yang Y, Duan Y, Li K, Liu S, Ye C, Lin D (2017) Dexamethasone distribution characteristic following controllable continuous sub-tenon drug delivery in rabbit. Drug Deliv 24(1):818\u2013824. https:\/\/doi.org\/10.1080\/10717544.2017.1324531","journal-title":"Drug Deliv"},{"issue":"5","key":"2637_CR41","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1080\/02713683.2020.1826979","volume":"46","author":"YH Yang","year":"2021","unstructured":"Yang YH, Hsu WC, Hsieh YT (2021) Anterior migration of triamcinolone acetonide after posterior subtenon injection for macular edema predisposes to intraocular pressure elevation. Curr Eye Res 46(5):689\u2013693. https:\/\/doi.org\/10.1080\/02713683.2020.1826979","journal-title":"Curr Eye Res"},{"key":"2637_CR42","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.addr.2018.03.001","volume":"126","author":"B Chiang","year":"2018","unstructured":"Chiang B, Jung JH, Prausnitz MR (2018) The suprachoroidal space as a route of administration to the posterior segment of the eye. Adv Drug Deliv Rev 126:58\u201366. https:\/\/doi.org\/10.1016\/j.addr.2018.03.001","journal-title":"Adv Drug Deliv Rev"},{"key":"2637_CR43","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/j.ejpb.2021.10.003","volume":"169","author":"I Sher","year":"2021","unstructured":"Sher I, Goldberg Z, Bubis E, Barak Y, Rotenstreich Y (2021) Suprachoroidal delivery of bevacizumab in rabbit in vivo eyes: Rapid distribution throughout the posterior segment. Eur J Pharm Biopharm 169:200\u2013210. https:\/\/doi.org\/10.1016\/j.ejpb.2021.10.003","journal-title":"Eur J Pharm Biopharm"},{"issue":"11","key":"2637_CR44","doi-asserted-by":"publisher","first-page":"e20038","DOI":"10.7759\/cureus.20038","volume":"13","author":"J Hanif","year":"2021","unstructured":"Hanif J, Iqbal K, Perveen F, Arif A, Iqbal RN, Jameel F, Hanif K, Seemab A, Khan AY, Ahmed M (2021) Safety and efficacy of suprachoroidal injection of triamcinolone in treating macular edema secondary to noninfectious uveitis. Cureus 13(11):e20038. https:\/\/doi.org\/10.7759\/cureus.20038","journal-title":"Cureus"},{"issue":"8","key":"2637_CR45","doi-asserted-by":"publisher","first-page":"703","DOI":"10.3390\/pharmaceutics12080703","volume":"12","author":"C Iovino","year":"2020","unstructured":"Iovino C, Mastropasqua R, Lupidi M, Bacherini D, Pellegrini M, Bernabei F, Borrelli E, Sacconi R, Carnevali A, D\u2019Aloisio R, Cerquaglia A, Finocchio L, Govetto A, Erba S, Triolo G, Di Zazzo A, Forlini M, Vagge A, Giannaccare G (2020) Intravitreal dexamethasone implant as a sustained release drug delivery device for the treatment of ocular diseases: a comprehensive review of the literature. Pharmaceutics 12(8):703. https:\/\/doi.org\/10.3390\/pharmaceutics12080703","journal-title":"Pharmaceutics"},{"issue":"3","key":"2637_CR46","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1080\/02713683.2018.1542736","volume":"44","author":"OJ Mezu-Ndubuisi","year":"2019","unstructured":"Mezu-Ndubuisi OJ, Wang Y, Schoephoerster J, Falero-Perez J, Zaitoun IS, Sheibani N, Gong S (2019) Intravitreal delivery of VEGF-A165-loaded PLGA microparticles reduces retinal vaso-obliteration in an in vivo mouse model of retinopathy of prematurity. Curr Eye Res 44(3):275\u2013286. https:\/\/doi.org\/10.1080\/02713683.2018.1542736","journal-title":"Curr Eye Res"},{"issue":"7","key":"2637_CR47","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1517\/17425247.2016.1163334","volume":"13","author":"R Bisht","year":"2016","unstructured":"Bisht R, Jaiswal JK, Chen YS, Jin J, Rupenthal ID (2016) Light-responsive in situ forming injectable implants for effective drug delivery to the posterior segment of the eye. Expert Opin Drug Deliv 13(7):953\u2013962. https:\/\/doi.org\/10.1517\/17425247.2016.1163334","journal-title":"Expert Opin Drug Deliv"},{"key":"2637_CR48","doi-asserted-by":"publisher","first-page":"108369","DOI":"10.1016\/j.exer.2020.108369","volume":"202","author":"S Naguib","year":"2021","unstructured":"Naguib S, Bernardo-Col\u00f3n A, Rex TS (2021) Intravitreal injection worsens outcomes in a mouse model of indirect traumatic optic neuropathy from closed globe injury. Exp Eye Res 202:108369. https:\/\/doi.org\/10.1016\/j.exer.2020.108369","journal-title":"Exp Eye Res"},{"key":"2637_CR49","doi-asserted-by":"publisher","first-page":"4928905","DOI":"10.1155\/2020\/4928905","volume":"2020","author":"B Urban","year":"2020","unstructured":"Urban B, Szwabowicz M, Bakunowicz-\u0141azarczyk A (2020) Effect of repeated intravitreal ranibizumab and aflibercept injections on the cornea in patients with age-related macular degeneration. J Ophthalmol 2020:4928905. https:\/\/doi.org\/10.1155\/2020\/4928905","journal-title":"J Ophthalmol"},{"issue":"4","key":"2637_CR50","doi-asserted-by":"publisher","first-page":"246","DOI":"10.2174\/1872211314666191224115211","volume":"13","author":"Z Qamar","year":"2019","unstructured":"Qamar Z, Qizilbash FF, Iqubal MK, Ali A, Narang JK, Ali J, Baboota S (2019) Nano-based drug delivery system: recent strategies for the treatment of ocular disease and future perspective. Recent Pat Drug Deliv Formul 13(4):246\u2013254. https:\/\/doi.org\/10.2174\/1872211314666191224115211","journal-title":"Recent Pat Drug Deliv Formul"},{"key":"2637_CR51","doi-asserted-by":"publisher","first-page":"110902","DOI":"10.1016\/j.colsurfb.2020.110902","volume":"190","author":"P Nirbhavane","year":"2020","unstructured":"Nirbhavane P, Sharma G, Singh B, Begum G, Jones MC, Rauz S, Vincent R, Denniston AK, Hill LJ, Katare OP (2020) Triamcinolone acetonide loaded-cationic nano-lipoidal formulation for uveitis: Evidences of improved biopharmaceutical performance and anti-inflammatory activity. Colloids Surf B Biointerfaces 190:110902. https:\/\/doi.org\/10.1016\/j.colsurfb.2020.110902","journal-title":"Colloids Surf B Biointerfaces"},{"issue":"4","key":"2637_CR52","doi-asserted-by":"publisher","first-page":"e1548","DOI":"10.1002\/wnan.1548","volume":"11","author":"DA Srinivasarao","year":"2019","unstructured":"Srinivasarao DA, Lohiya G, Katti DS (2019) Fundamentals, challenges, and nanomedicine-based solutions for ocular diseases. Wiley Interdiscip Rev Nanomed Nanobiotechnol 11(4):e1548. https:\/\/doi.org\/10.1002\/wnan.1548","journal-title":"Wiley Interdiscip Rev Nanomed Nanobiotechnol"},{"issue":"22","key":"2637_CR53","doi-asserted-by":"publisher","first-page":"12368","DOI":"10.3390\/ijms222212368","volume":"22","author":"A Vaneev","year":"2021","unstructured":"Vaneev A, Tikhomirova V, Chesnokova N, Popova E, Beznos O, Kost O, Klyachko N (2021) Nanotechnology for topical drug delivery to the anterior segment of the eye. Int J Mol Sci 22(22):12368. https:\/\/doi.org\/10.3390\/ijms222212368","journal-title":"Int J Mol Sci"},{"key":"2637_CR54","doi-asserted-by":"publisher","first-page":"118943","DOI":"10.1016\/j.ijpharm.2019.118943","volume":"575","author":"A Yu","year":"2020","unstructured":"Yu A, Shi H, Liu H, Bao Z, Dai M, Lin D, Lin D, Xu X, Li X, Wang Y (2020) Mucoadhesive dexamethasone-glycol chitosan nanoparticles for ophthalmic drug delivery. Int J Pharm 575:118943. https:\/\/doi.org\/10.1016\/j.ijpharm.2019.118943","journal-title":"Int J Pharm"},{"key":"2637_CR55","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.jconrel.2019.05.034","volume":"306","author":"RC Cooper","year":"2019","unstructured":"Cooper RC, Yang H (2019) Hydrogel-based ocular drug delivery systems: emerging fabrication strategies, applications, and bench-to-bedside manufacturing considerations. J Control Release 306:29\u201339. https:\/\/doi.org\/10.1016\/j.jconrel.2019.05.034","journal-title":"J Control Release"},{"key":"2637_CR56","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.ejpb.2017.12.019","volume":"124","author":"R Egbu","year":"2018","unstructured":"Egbu R, Brocchini S, Khaw PT, Awwad S (2018) Antibody loaded collapsible hyaluronic acid hydrogels for intraocular delivery. Eur J Pharm Biopharm 124:95\u2013103. https:\/\/doi.org\/10.1016\/j.ejpb.2017.12.019","journal-title":"Eur J Pharm Biopharm"},{"issue":"1","key":"2637_CR57","doi-asserted-by":"publisher","first-page":"24115","DOI":"10.1038\/s41598-021-03605-0","volume":"11","author":"DJ Kim","year":"2021","unstructured":"Kim DJ, Jung MY, Park JH, Pak HJ, Kim M, Chuck RS, Park CY (2021) Moxifloxacin releasing intraocular implant based on a cross-linked hyaluronic acid membrane. Sci Rep 11(1):24115. https:\/\/doi.org\/10.1038\/s41598-021-03605-0","journal-title":"Sci Rep"},{"issue":"1","key":"2637_CR58","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.1080\/10717544.2021.1938756","volume":"28","author":"Y Su","year":"2021","unstructured":"Su Y, Zhang B, Sun R, Liu W, Zhu Q, Zhang X, Wang R, Chen C (2021) PLGA-based biodegradable microspheres in drug delivery: recent advances in research and application. Drug Deliv 28(1):1397\u20131418. https:\/\/doi.org\/10.1080\/10717544.2021.1938756","journal-title":"Drug Deliv"},{"key":"2637_CR59","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.actbio.2018.09.039","volume":"80","author":"K Lee","year":"2018","unstructured":"Lee K, Song HB, Cho W, Kim JH, Kim JH, Ryu W (2018) Intracorneal injection of a detachable hybrid microneedle for sustained drug delivery. ACTA Biomater 80:48\u201357. https:\/\/doi.org\/10.1016\/j.actbio.2018.09.039","journal-title":"ACTA Biomater"},{"issue":"1","key":"2637_CR60","doi-asserted-by":"publisher","first-page":"4433","DOI":"10.1038\/s41467-018-06981-w","volume":"9","author":"A Than","year":"2018","unstructured":"Than A, Liu C, Chang H, Duong PK, Cheung CMG, Xu C, Wang X, Chen P (2018) Self-implantable double-layered micro-drug-reservoirs for efficient and controlled ocular drug delivery. Nat Commun 9(1):4433. https:\/\/doi.org\/10.1038\/s41467-018-06981-w","journal-title":"Nat Commun"},{"issue":"2","key":"2637_CR61","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1167\/iovs.17-23066","volume":"59","author":"YC Liu","year":"2018","unstructured":"Liu YC, Ng XW, Teo EPW, Ang HP, Lwin NC, Chan NSW, Venkatraman SS, Wong TT, Mehta JS (2018) A biodegradable, sustained-released, tacrolimus microfilm drug delivery system for the management of allergic conjunctivitis in a mouse model. Invest Ophthalmol Vis Sci 59(2):675\u2013684. https:\/\/doi.org\/10.1167\/iovs.17-23066","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"5","key":"2637_CR62","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1167\/tvst.6.5.9","volume":"6","author":"YC Liu","year":"2017","unstructured":"Liu YC, Ng AHC, Ng XW, Yan P, Venkatraman SS, Mehta JS, Wong TT (2017) Evaluation of a sustained-release prednisolone acetate biodegradable subconjunctival implant in a non-human primate model. Transl Vis Sci Technol 6(5):9. https:\/\/doi.org\/10.1167\/tvst.6.5.9","journal-title":"Transl Vis Sci Technol"},{"issue":"1","key":"2637_CR63","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1167\/iovs.16-20339","volume":"58","author":"C Zhou","year":"2017","unstructured":"Zhou C, Robert MC, Kapoulea V, Lei F, Stagner AM, Jakobiec FA, Dohlman CH, Paschalis EI (2017) Sustained subconjunctival delivery of infliximab protects the cornea and retina following alkali burn to the eye. Invest Ophthalmol Vis Sci 58(1):96\u2013105. https:\/\/doi.org\/10.1167\/iovs.16-20339","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"2637_CR64","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/j.ejpb.2019.01.024","volume":"136","author":"N Nagai","year":"2019","unstructured":"Nagai N, Saijo S, Song Y, Kaji H, Abe T (2019) A drug refillable device for transscleral sustained drug delivery to the retina. Eur J Pharm Biopharm 136:184\u2013191. https:\/\/doi.org\/10.1016\/j.ejpb.2019.01.024","journal-title":"Eur J Pharm Biopharm"},{"issue":"8","key":"2637_CR65","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1167\/tvst.9.8.5","volume":"9","author":"C Zhou","year":"2020","unstructured":"Zhou C, Singh A, Qian G, Wolkow N, Dohlman CH, Vavvas DG, Chodosh J, Paschalis EI (2020) Microporous drug delivery system for sustained anti-VEGF delivery to the eye. Transl Vis Sci Technol 9(8):5. https:\/\/doi.org\/10.1167\/tvst.9.8.5","journal-title":"Transl Vis Sci Technol"},{"key":"2637_CR66","first-page":"3556","volume":"17","author":"K Tsuruma","year":"2011","unstructured":"Tsuruma K, Tanaka Y, Shimazawa M, Mashima Y, Hara H (2011) Unoprostone reduces oxidative stress- and light-induced retinal cell death, and phagocytotic dysfunction, by activating BK channels. Mol Vis 17:3556\u20133565","journal-title":"Mol Vis"},{"issue":"15","key":"2637_CR67","doi-asserted-by":"publisher","first-page":"6527","DOI":"10.1167\/iovs.16-20453","volume":"57","author":"N Nagai","year":"2016","unstructured":"Nagai N, Koyanagi E, Izumida Y, Liu J, Katsuyama A, Kaji H, Nishizawa M, Osumi N, Kondo M, Terasaki H, Mashima Y, Nakazawa T, Abe T (2016) Long-term protection of genetically ablated rabbit retinal degeneration by sustained transscleral unoprostone delivery. Invest Ophthalmol Vis Sci 57(15):6527\u20136538. https:\/\/doi.org\/10.1167\/iovs.16-20453","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"2","key":"2637_CR68","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1167\/iovs.17-22429","volume":"59","author":"N Nagai","year":"2018","unstructured":"Nagai N, Yamada S, Kawasaki J, Koyanagi E, Saijo S, Kaji H, Nishizawa M, Nakazawa T, Abe T (2018) Pharmacokinetic and safety evaluation of a transscleral sustained unoprostone release device in monkey eyes. Invest Ophthalmol Vis Sci 59(2):644\u2013652","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"2637_CR69","doi-asserted-by":"publisher","first-page":"118458","DOI":"10.1016\/j.ijpharm.2019.118458","volume":"567","author":"N Nagai","year":"2019","unstructured":"Nagai N, Nezhad ZK, Daigaku R, Saijo S, Song Y, Terata K, Hoshi A, Nishizawa M, Nakazawa T, Kaji H, Abe T (2019) Transscleral sustained ranibizumab delivery using an episcleral implantable device: Suppression of laser-induced choroidal neovascularization in rats. Int J Pharm 567:118458. https:\/\/doi.org\/10.1016\/j.ijpharm.2019.118458","journal-title":"Int J Pharm"},{"issue":"3","key":"2637_CR70","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1007\/s10544-019-0411-z","volume":"21","author":"Y Sato","year":"2019","unstructured":"Sato Y, Nagai N, Abe T, Kaji H (2019) A multilayered sheet-type device capable of sustained drug release and deployment control. Biomed Microdevices 21(3):60. https:\/\/doi.org\/10.1007\/s10544-019-0411-z","journal-title":"Biomed Microdevices"},{"issue":"4","key":"2637_CR71","doi-asserted-by":"publisher","first-page":"436","DOI":"10.3390\/mi11040436","volume":"11","author":"H Kojima","year":"2020","unstructured":"Kojima H, Raut B, Chen LJ, Nagai N, Abe T, Kaji H (2020) A 3D printed self-sustainable cell-encapsulation drug delivery device for periocular transplant-based treatment of retinal degenerative diseases. Micromachines Basel 11(4):436. https:\/\/doi.org\/10.3390\/mi11040436","journal-title":"Micromachines Basel"},{"key":"2637_CR72","doi-asserted-by":"publisher","first-page":"100764","DOI":"10.1016\/j.preteyeres.2019.05.005","volume":"73","author":"FL Munier","year":"2019","unstructured":"Munier FL, Beck-Popovic M, Chantada GL, Cobrinik D, Kivel\u00e4 TT, Lohmann D, Maeder P, Moll AC, Carcaboso AM, Moulin A, Schaiquevich P, Bergin C, Dyson PJ, Houghton S, Puccinelli F, Vial Y, Gaillard MC, Stathopoulos C (2019) Conservative management of retinoblastoma: challenging orthodoxy without compromising the state of metastatic grace Alive, with good vision and no comorbidity. Prog Retin Eye Res 73:100764. https:\/\/doi.org\/10.1016\/j.preteyeres.2019.05.005","journal-title":"Prog Retin Eye Res"},{"issue":"12","key":"2637_CR73","doi-asserted-by":"publisher","first-page":"1551","DOI":"10.1038\/s41388-017-0050-x","volume":"37","author":"ID Fabian","year":"2018","unstructured":"Fabian ID, Onadim Z, Karaa E, Duncan C, Chowdhury T, Scheimberg I, Ohnuma SI, Reddy MA, Sagoo MS (2018) The management of retinoblastoma. Oncogene 37(12):1551\u20131560. https:\/\/doi.org\/10.1038\/s41388-017-0050-x","journal-title":"Oncogene"},{"key":"2637_CR74","doi-asserted-by":"publisher","first-page":"109799","DOI":"10.1016\/j.msec.2019.109799","volume":"103","author":"AI Cocarta","year":"2019","unstructured":"Cocarta AI, Hobzova R, Sirc J, Cerna T, Hrabeta J, Svojgr K, Pochop P, Kodetova M, Jedelska J, Bakowsky U, Uhlik J (2019) Hydrogel implants for transscleral drug delivery for retinoblastoma treatment. Mater Sci Eng C Mater Biol Appl 103:109799. https:\/\/doi.org\/10.1016\/j.msec.2019.109799","journal-title":"Mater Sci Eng C Mater Biol Appl"},{"key":"2637_CR75","doi-asserted-by":"publisher","first-page":"120832","DOI":"10.1016\/j.ijpharm.2021.120832","volume":"606","author":"R Hobzova","year":"2021","unstructured":"Hobzova R, Kodetova M, Pochop P, Uhlik J, Dunovska K, Svojgr K, Hrabeta J, Feriancikova B, Cocarta AI, Sirc J (2021) Hydrogel implants for transscleral diffusion delivery of topotecan: In vivo proof of concept in a rabbit eye model. Int J Pharm 606:120832. https:\/\/doi.org\/10.1016\/j.ijpharm.2021.120832","journal-title":"Int J Pharm"},{"issue":"1","key":"2637_CR76","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1089\/jop.2018.0043","volume":"35","author":"JC Covert","year":"2019","unstructured":"Covert JC, Thomasy SM, Kado-Fong H, Kon LN, Kass PH, Reilly CM, Lappin MR, Margulies BJ, Maggs DJ (2019) Pilot study of the safety and tolerability of a subconjunctival penciclovir implant in cats experimentally infected with herpesvirus. J Ocul Pharmacol Ther 35(1):38\u201349. https:\/\/doi.org\/10.1089\/jop.2018.0043","journal-title":"J Ocul Pharmacol Ther"},{"issue":"4","key":"2637_CR77","doi-asserted-by":"publisher","first-page":"1652","DOI":"10.1208\/s12249-018-0978-3","volume":"19","author":"AGR Solano","year":"2018","unstructured":"Solano AGR, de F\u00e1tima PA, de Faria LGA, Fialho SL, de Oliveira Patricio PS, da Silva-Cunha A, Fulg\u00eancio GO, da Silva GR, Pianetti GA (2018) Etoposide-loaded poly(lactic-co-glycolic acid) intravitreal implants in vitro and in vivo evaluation. AAPS Pharm Sci Tech 19(4):1652\u20131661. https:\/\/doi.org\/10.1208\/s12249-018-0978-3","journal-title":"AAPS Pharm Sci Tech"},{"key":"2637_CR78","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.jconrel.2018.05.030","volume":"283","author":"C Wang","year":"2018","unstructured":"Wang C, Seo SJ, Kim JS, Lee SH, Jeon JK, Kim JW, Kim KH, Kim JK, Park J (2018) Intravitreal implantable magnetic micropump for on-demand VEGFR-targeted drug delivery. J Control Release 283:105\u2013112. https:\/\/doi.org\/10.1016\/j.jconrel.2018.05.030","journal-title":"J Control Release"},{"key":"2637_CR79","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.jconrel.2019.01.007","volume":"296","author":"S Iyer","year":"2019","unstructured":"Iyer S, Radwan AE, Hafezi-Moghadam A, Malyala P, Amiji M (2019) Long-acting intraocular delivery strategies for biological therapy of age-related macular degeneration. J Control Release 296:140\u2013149. https:\/\/doi.org\/10.1016\/j.jconrel.2019.01.007","journal-title":"J Control Release"},{"issue":"6","key":"2637_CR80","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1111\/aos.13744","volume":"96","author":"S Leinonen","year":"2018","unstructured":"Leinonen S, Immonen I, Kotaniemi K (2018) Fluocinolone acetonide intravitreal implant (Retisert\u00ae ) in the treatment of sight threatening macular oedema of juvenile idiopathic arthritis-related uveitis. Acta Ophthalmol 96(6):648\u2013651. https:\/\/doi.org\/10.1111\/aos.13744","journal-title":"Acta Ophthalmol"},{"issue":"7","key":"2637_CR81","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1080\/17425247.2019.1618829","volume":"16","author":"F Behar-Cohen","year":"2019","unstructured":"Behar-Cohen F (2019) Recent advances in slow and sustained drug release for retina drug delivery. Expert Opin Drug Deliv 16(7):679\u2013686. https:\/\/doi.org\/10.1080\/17425247.2019.1618829","journal-title":"Expert Opin Drug Deliv"},{"key":"2637_CR82","doi-asserted-by":"publisher","DOI":"10.1177\/11206721211046718","author":"L Miguel-Escuder","year":"2021","unstructured":"Miguel-Escuder L, Olate-P\u00e9rez \u00c1, Sala-Puigdoners A, Moll-Udina A, Figueras-Roca M, Navarro-Angulo MJ, Ad\u00e1n A, Pelegr\u00edn L (2021) Intravitreal fluocinolone acetonide implant for the treatment of persistent post-surgical cystoid macular edema in vitrectomized eyes. Eur J Ophthalmol. https:\/\/doi.org\/10.1177\/11206721211046718","journal-title":"Eur J Ophthalmol"},{"issue":"8","key":"2637_CR83","doi-asserted-by":"publisher","first-page":"1694","DOI":"10.1016\/j.drudis.2019.05.031","volume":"24","author":"Y Cao","year":"2019","unstructured":"Cao Y, Samy KE, Bernards DA, Desai TA (2019) Recent advances in intraocular sustained-release drug delivery devices. Drug Discov Today 24(8):1694\u20131700. https:\/\/doi.org\/10.1016\/j.drudis.2019.05.031","journal-title":"Drug Discov Today"},{"issue":"11","key":"2637_CR84","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1007\/s40265-020-01344-6","volume":"80","author":"A Lee","year":"2020","unstructured":"Lee A, Blair HA (2020) Dexamethasone intracanalicular insert: a review in treating post-surgical ocular pain and inflammation. Drugs 80(11):1101\u20131108. https:\/\/doi.org\/10.1007\/s40265-020-01344-6","journal-title":"Drugs"},{"issue":"1","key":"2637_CR85","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.jaapos.2020.10.001","volume":"25","author":"RH Trivedi","year":"2021","unstructured":"Trivedi RH, Wilson ME (2021) A sustained-release intracanalicular dexamethasone insert (Dextenza) for pediatric cataract surgery. J AAPOS 25(1):43\u201345. https:\/\/doi.org\/10.1016\/j.jaapos.2020.10.001","journal-title":"J AAPOS"},{"issue":"6","key":"2637_CR86","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1007\/s40266-020-00769-8","volume":"37","author":"M Shirley","year":"2020","unstructured":"Shirley M (2020) Bimatoprost implant: first approval. Drugs Aging 37(6):457\u2013462. https:\/\/doi.org\/10.1007\/s40266-020-00769-8","journal-title":"Drugs Aging"},{"issue":"1","key":"2637_CR87","doi-asserted-by":"publisher","first-page":"148","DOI":"10.18240\/ijo.2021.01.21","volume":"14","author":"NP Kesav","year":"2021","unstructured":"Kesav NP, Young CEC, Ertel MK, Seibold LK, Kahook MY (2021) Sustained-release drug delivery systems for the treatment of glaucoma. Int J Ophthalmol 14(1):148\u2013159. https:\/\/doi.org\/10.18240\/ijo.2021.01.21","journal-title":"Int J Ophthalmol"}],"container-title":["International Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10792-023-02637-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10792-023-02637-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10792-023-02637-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,30]],"date-time":"2023-06-30T11:08:09Z","timestamp":1688123289000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10792-023-02637-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,30]]},"references-count":87,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2023,7]]}},"alternative-id":["2637"],"URL":"https:\/\/doi.org\/10.1007\/s10792-023-02637-x","relation":{},"ISSN":["1573-2630"],"issn-type":[{"value":"1573-2630","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,30]]},"assertion":[{"value":"13 September 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 January 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 January 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Yun-Yi Cong, Bin Fan, Zi-Yuan Zhang and Guang-Yu Li declare they have no financial interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This article does not contain any studies with human participants or animals performed by any of the authors.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}}]}}